The Dow Jones Industrial Average closed up 34.72 points, or 0.2%, at a record 20,810.32, led by gains in health-care stocks Pfizer Inc.(PFE) and Johnson & Johnson ... www.marketwatch.com/story/by-one-measure-stock- …
NASDAQ
The performance of Pfizer Inc. (PFE) does little to inspire confidence in investors. However, for traders it’s an entirely different story. The recent downtrend in the stock’s performance is notable, and after multiple …
Pfizer
The Dow Jones Industrial Average , which had fluctuated between slight gains and losses earlier, was last up 48 points, or 0.2%, at 20,823, led by gains in health-care stocks Pfizer Inc.(PFE) and Johnson ... story/by-one …
MARKET SNAPSHOT
And finally, we get to Pfizer (PFE). You have champagne… you have lingerie… I suppose it’s only appropriate that Viagra comes next. All …
Stock picks
The crown jewels of Bristol-Myers Squibb are the immuno-oncology drug Opdivo and the anticoagulant Eliquis, which Bristol-Myers Squibb splits …
Bristol Myers Squibb
CHICAGO, Feb. 22, 2017 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMD, M, …
Finally, Vanguard Group Inc. boosted its position in Pfizer by 1.6% in the second quarter. (NYSE:PFE) may hit a high of $52. The research firm Initiated the stock to Neutral. Monroe Bank & Trust MI's holdings in Pfizer were …
Pfizer